Announced Tue, 14 Jul · 13:41 IST
Compliance Certificate under Reg 74(5) for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹37.50
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.7-1.6-2.7-7.7-12.3-20.9————
Up moveDown movePending
AI summary
Bacil Pharma has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026, along with a certificate from its Registrar Bigshare Services. It confirms securities received for dematerialisation were processed, share certificates mutilated and cancelled, and depository names updated as registered owners within 15 days. This is a routine quarterly compliance filing required of listed companies.
Likely market impact
Routine procedural filing with no material effect on shareholders or stock price.